Physician

Marc C. Peden, MD

According to 2025 Medicare claims, Marc Peden, MD (NPI: 1316028335) practices ophthalmology in the Tampa, FL market, with the plurality of this provider's patient population coming from Hillsborough, FL. This provider's primary affiliated billing organization is RETINA ASSOCIATES OF FLORIDA, P.A. (NPI: 1811959570; TIN: 592695288) and primary practice location at 33609-4614.

Peden's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 827 traditional Medicare patients, billed 63,347 HCPCS/CPT codes, and received $2,327,422 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 461 prescription claims across 137 beneficiaries totaling $41,945 in drug costs, led by Rhopressa (Netarsudil Mesylate). Open Payments data shows 44 records totaling $4,546. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $22,835 to $41,945. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.8M$3.7M2015 Medicare payment: $2,491,283 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,472,526 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $3,660,945 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $3,566,230 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $3,315,717 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $3,092,465 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,810,085 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,595,631 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,617,579 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,327,422 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201575710,742$2,491,283
201675410,727$2,472,526
201794616,300$3,660,945
201896716,214$3,566,230
20191,00714,881$3,315,717
202087613,575$3,092,465
202191712,884$2,810,085
202290319,518$2,595,631
202388264,411$2,617,579
202482763,347$2,327,422

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$28K$56K2015 Drug cost: $22,835 (USD; Tot_Drug_Cst)2016 Drug cost: $24,746 (USD; Tot_Drug_Cst)2017 Drug cost: $32,074 (USD; Tot_Drug_Cst)2018 Drug cost: $47,083 (USD; Tot_Drug_Cst)2019 Drug cost: $54,969 (USD; Tot_Drug_Cst)2020 Drug cost: $52,797 (USD; Tot_Drug_Cst)2021 Drug cost: $56,319 (USD; Tot_Drug_Cst)2022 Drug cost: $54,789 (USD; Tot_Drug_Cst)2023 Drug cost: $54,256 (USD; Tot_Drug_Cst)2024 Drug cost: $41,945 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201563208$22,835
201681247$24,746
201795301$32,074
2018120384$47,083
2019125413$54,969
2020140534$52,797
2021150429$56,319
2022131481$54,789
2023138482$54,256
2024137461$41,945

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye3191,107$99
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more237369$87
92014Established patient complete exam of visual system488704$82
92134Imaging of retina7701,447$29
J2777Injection, faricimab-svoa, 0.1 mg22555,800$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RhopressaNetarsudil Mesylate11397$3,627
Loteprednol EtabonateLoteprednol Etabonate22553$3,441
Prednisolone AcetatePrednisolone Acetate913,991$3,023
MoxifloxacinMoxifloxacin Hcl45732$997
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat403,125$600

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.44$4,546EyePoint Pharmaceuticals US, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Marc C. Peden, MD?

Tedicare shows public-source Medicare data for Marc C. Peden, MD (NPI 1316028335), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Marc C. Peden, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Marc C. Peden, MD?

Marc C. Peden, MD is linked to RETINA ASSOCIATES OF FLORIDA, P.A. (billing NPI 1811959570) in the available physician profile data.

Does Marc C. Peden, MD have Open Payments data?

Marc C. Peden, MD has 44 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.